 |
 |
Sent from my BlackBerry® smartphone, powered by Easyblaze -----Original Message----- From: Emel Kahraman <[log in to unmask]> Sender: A UK-based worldwide e-mail broadcast system mailing list <[log in to unmask]> Date: Fri, 17 Jun 2016 09:32:52 To: <[log in to unmask]> Reply-To: Emel Kahraman <[log in to unmask]> Subject: New Job: PRINCIPAL BIOSTATISTICIAN_ASSOCIATE DIRECTOR BIOSTATISTICIAN - NEW JERSEY - USA Dear Allstat, HYDROGEN IS PROUD TO ANNOUNCE THAT WE ARE CURRENTLY EXCLUSIVELY PARTNERING WITH AN INTERNATIONAL, INNOVATIVE AND LEADING PHARMACEUTICAL COMPANY A full job spec is available upon request. Interview slots (TC's) are available for next week and the week after. F2F interviews will happen between the 18th and 21st of July PRINCIPAL BIOSTATISTICIAN/ASSOCIATE DIRECTOR PERMANENT OFFICE BASED NEW JERSEY Our client is a research driven, global, integrated pharmaceutical company who have their offices in over 20 countries and is at the moment looking to build the biometrics team in their US offices. We have already successfully secured one Biostatistical professional to join them and are at the moment looking for a second one. Our client is looking for a highly experienced biostatistical professional that has the capability to work independently, who is innovative and someone who can think outside the box. You will be expected to provide experienced Statistical insight to the Clinical Development Plans, Clinical Study Protocols and Clinical Study Reports across the Innovative and Approved products/Branded generic portfolio globally. MAIN RESPONSIBILITIES * Responsible for the analysis and interpretation of the data for the Innovative portfolio of small molecules and Biologic projects. These include clinical Phases I - II - III - IV. * Responsible for the analysis and interpretation of the data for Regulatory and Market access projects with Approved/Branded generic portfolio, including Devices. * You will be expected to work efficiently with the Global Programming group, study data management group and external providers. * High-quality inputs into the study design. * Expected to demonstrate progressive thinking by suggesting alternative designs and innovative/novel analyses methods. MINIMUN REQUIREMENTS * Minimum MSc level, PhD preferred * Minimum 5 years' experience in a similar senior role handling design and analysis of Phase I to IV clinical studies * Responsibility for the design and analysis plans for multiple studies using innovative analyses methods. * Deep understanding of drug development and the application of statistical rigour to design efficient studies that answer complex scientific questions. * Demonstrated competence in statistical discipline (ie. Frequentist and Bayesian) * Multivariate methods (MLR, MANOVA, ...), non-parametric methods, categorical analysis, exploratory and confirmatory factor analysis * Diplomatically assertive and clear communicator. * Ability to explain statistics to non-statisticians. * Ability to influence peers and senior managers * Ability to work cross culture / cross geography areas * Direct exposure to mature market Regulator (FDA, EMA, ...) is desirable * External recognition desirable (ie. Statistics Journal Reviewer) FINANCIAL REWARD Very competitive salary Benefits * Up to 15% bonus * 100% coverage of the costs by the employer o Medical Insurance, Dental Insurance, Vision Insurance, Life Insurance, Disability benefits, Pension, Holidays, ... If you like to discuss this position then please send an updated version of your cv to [log in to unmask]<mailto:[log in to unmask]> or alternatively you can call me on +44 (0)20 7002 02 92 Regards Emel Kahraman Senior Consultant Life Sciences Practice D +44 (0)20 7002 0292 30 Eastcheap London EC3M 1HD T +44 (0)20 7090 1611 www.hydrogengroup.com<http://www.hydrogengroup.com/?utm_source=internal&utm_medium=signature&utm_campaign=address> This email is confidential and is intended for the addressee(s) only. If you are not the named addressee you may not use it, copy it or disclose it to any other person. If you have received this message in error please contact [[log in to unmask]]. Any views or opinions presented are solely those of the originator and do not necessarily represent those of Hydrogen Group plc or any of its affiliates. On the basis that you are the intended recipient, then receipt of this email by you represents your confirmation that you agree, or continue to agree, to be bound by our standard Terms and Conditions applicable to the transaction to which this email relates. If you require a copy (or a replacement copy) of the applicable standard Terms and Conditions please email your request by return. If you have received this as part of a direct marketing campaign in error and no longer wish to receive such material from Hydrogen, please notify us by replying to this email. Hydrogen Group plc Hydrogen Group plc is registered in England and Wales, no. 5563206 Registered office address: 30-40 Eastcheap, London EC3M 1HD Hydrogen International Ltd Hydrogen International Ltd is registered in England and Wales, no. 3876449 Registered office address: 30-40 Eastcheap, London EC3M 1HD Hydrogen UK Ltd Hydrogen UK Ltd is registered in England and Wales, no. 3286747 Registered office address: 30-40 Eastcheap, London EC3M 1HD ______________________________________________________________________ This email has been scanned by the Symantec Email Security.cloud service. For more information please visit http://www.symanteccloud.com ______________________________________________________________________ You may leave the list at any time by sending the command SIGNOFF allstat to [log in to unmask], leaving the subject line blank. You may leave the list at any time by sending the command SIGNOFF allstat to [log in to unmask], leaving the subject line blank.